ArticlebioRxiv : the preprint server for biology2026
A Temporal Reliability and Sustainability Score Framework for Ranking Heart Rate Variability Metrics During Pharmacological Autonomic Blockade in Rats.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background: While Heart Rate Variability (HRV) is a cornerstone of non-invasive autonomic assessment, the sensitivity and sustainability of specific HRV parameters remain debated. This study introduces a "sustainability score" to systematically validate which metrics best reflect autonomic nervous system (ANS) modulation following pharmacological blockade. Methods: Ten male Sprague-Dawley rats were implanted with ECG electrodes. After recovery, rats underwent randomized atropine (1 mg/kg, intraperitoneal) and propranolol (10 mg/kg, intraperitoneal) sessions separated by at least 3 days. Baseline ECG was recorded for 30 min before each session, followed by 90-min post-drug ECG recording. HRV parameters were analyzed in sequential 15-min and 30-min segments. Reliability was assessed using average p-values across post-drug segments and a sustainability score, defined as the number of segments significantly different from baseline. Results: After atropine, HF Power showed the strongest rapid parasympathetic-related response in 15-min segments, with the lowest average p-value (0.1476) and highest sustainability score (4), followed by RSA (p=0.16148; score=4). HFn was less reliable in 15-min segments (p=0.23147; score=2) but became the most reliable parasympathetic-related metric in 30-min segments (p=0.0001; score=3). After propranolol, SI was the most reliable sympathetic-related metric in both 15-min (p=0.18225; score=2) and 30-min segments (p=0.0393; score=2), while SD2/SD1 showed the strongest 30-min sympathovagal-balance response (p=0.0200; score=3). Conclusion: HF Power is recommended for rapid parasympathetic-related assessment in short windows, HFn for longer-window parasympathetic assessment, SI for sympathetic-assessment, and SD2/SD1 for 30-min sympathovagal-balance analysis. Sustainability scoring provides a structured framework for selecting ECGderived autonomic markers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.